Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PathXL (formerly i-Path Diagnostics) was a digital pathology company that developed software solutions for the management and analysis of digital slides. Founded as a spin-out from Queen's University Belfast, the company provided a web-based platform used by pathologists, researchers, and educators to view and share high-resolution images. Their technology included automated image analysis tools, particularly for oncology research and clinical trials. The company's products supported biobanking, education, and clinical workflow efficiency. In 2016, PathXL was acquired by Philips to strengthen its computational pathology and integrated diagnostics business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on i-Path Diagnostics.